MAP2K7 and non-small cell lung carcinoma: To further validate our hypothesis that combining autophagy and MEK inhibitors could be a novel therapeutic strategy specifically in the treatment of KL NSCLC, we first assessed the anti-tumor effect of the combination therapy in established KL and KP TDCL-induced allograft tumors in immunodeficient NCr nude mice.